Alzheimer's Disease Nursing CE Course for APRNs
Tracking # 20-1373885
Course overview
This course reviews Alzheimer's disease (AD), including relevant statistics, pathophysiology, screening, diagnostic criteria, and pharmacologic and nonpharmacologic treatment strategies.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Certified Nurse Midwife
1h
Pharmacotherapeutics continuing education in the area of certification
2.5h
Practice-Focused Continuing Education
Certified Nurse Practitioner
2.5h
Practice-Focused Continuing Education
1h
Pharmacotherapeutics continuing education in the area of certification
Clinical Nurse Specialist
1h
Pharmacotherapeutics continuing education in the area of certification
2.5h
Practice-Focused Continuing Education
Registered Nurse Practitioner
3.5h
Practice-Focused Continuing Education
District of Columbia Board of Nursing
Certified Nurse Midwife
2.5h
Relevant to Clinical Nurse Midwife Specialty
1h
Pharmacology Component
Clinical Nurse Specialist
1h
Pharmacology Component
2.5h
Relevant to Clinical Nurse Specialty
Nurse Practitioner
2.5h
Relevant to Nurse Practitioner Specialty
1h
Pharmacology Component
Florida Board of Nursing
Advanced Practice Registered Nurse
2.5h
General
1h
Pharmacology for Autonomous Practice Initial Certification
Georgia Board of Nursing
Registered Professional Nurse
3.5h
General
Mississippi Board of Nursing
Registered Nurse
3.5h
Continuing education related to nursing
New Mexico Board of Nursing
Certified Nurse Practitioner
2.5h
Continuing education relevant to CNP nursing specialty
1h
Continuing education related to pharmacology
Clinical Nurse Specialist
2.5h
Continuing education relevant to CNS nursing specialty
1h
Continuing education related to pharmacology
South Carolina Board of Nursing
Advanced Practice Registered Nurse
2.5h
General
1h
Pharmacotherapeutics
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
2.5h
Clinical Management of Patients
1h
Prescriptive Authority Privilege (RXA) pharmacotherapeutic